The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

In­vi­tae sets up shop in North Car­oli­na as part of plan to rapid­ly ex­pand its ge­net­ic test­ing man­u­fac­tur­ing

5 years ago

Zymer­gen's bid to dis­rupt a $3T in­dus­tri­al man­u­fac­tur­ing mar­ket goes vi­ral, earn­ing a mas­sive $500M IPO

5 years ago
Financing

Bris­tol My­ers finds a home for 1st EU cell ther­a­py site, clear­ing land near Am­s­ter­dam air­port for easy lo­gis­tics

5 years ago
Cell/Gene Tx

Why re­mote drug man­u­fac­tur­ing eval­u­a­tions won't re­al­ly re­duce FDA's back­log of in­spec­tions

5 years ago
FDA+

House De­moc­rats call on Emer­gent ex­ecs to tes­ti­fy on qual­i­ty is­sues next month

5 years ago
Pharma
FDA+

FDA lays the ham­mer on Emer­gen­t's Bal­ti­more plant af­ter J&J de­ba­cle, halt­ing all pro­duc­tion in un­usu­al move

5 years ago
R&D

Abzena picks North Car­oli­na as the home for its 6th man­u­fac­tur­ing site, plans to add 325 jobs in San­ford

5 years ago
Outsourcing

Avro­bio is us­ing 'pod­s' to cre­ate gene ther­a­pies, and it be­lieves the ap­proach could change the game al­to­geth­er

5 years ago
R&D

FDA blasts Colom­bian drug man­u­fac­tur­er in warn­ing let­ter for not prop­er­ly ad­dress­ing API flaws

5 years ago
R&D

Covid-19 man­u­fac­tur­ing roundup: Mod­er­na eyes Nexus' Wis­con­sin plant for vac­cine boost; Catal­ent wraps up plant project

5 years ago
Coronavirus

Launched by MIT grads, a small start­up gets $20M to back a ro­bot­ics rev­o­lu­tion in cell ther­a­py man­u­fac­tur­ing

5 years ago
Startups

Sanofi un­veils $476M vac­cine plant in Sin­ga­pore, bring­ing its to­tal out­lay to $1.7B in the field for past year

5 years ago
Deals

Scoop: Fer­ring, Black­stone’s $570M gene ther­a­py ven­ture has im­plod­ed af­ter CMC is­sues stymied a once high-pro­file quest

5 years ago
FDA+

Man­u­fac­tur­ing brief­ing: Af­ter J&J-Emer­gent mix­up, few­er dos­es ex­pect­ed in US next week; Boehringer taps Ox­ford for vi­ral vec­tors

5 years ago
R&D

CD­MO Ster­ling ac­quires ADC Bio, ramp­ing up ca­pac­i­ty for an­ti­body-drug con­ju­gate man­u­fac­tur­ing work

5 years ago
Deals

FDA in­spec­tion of Emer­gent’s Bal­ti­more site in 2020 rais­es new ques­tions

5 years ago
FDA+

Re­call re­port: A-S pulls near­ly 200,000 ac­eta­minophen bot­tles off shelves; Apo­tex yanks AD­HD med

5 years ago
Pharma
FDA+

Catal­ent pledges to in­crease pro­duc­tion of Mod­er­na vac­cine at its In­di­ana fill-fin­ish plant

5 years ago
Deals

2,400 peo­ple re­main with­out rare dis­ease drug as Take­da man­u­fac­tur­ing woes con­tin­ue

5 years ago
Pharma

Af­ter mil­lions of Covid vac­cine dos­es were botched, the feds hand con­trol of a trou­bled Emer­gent Bio fa­cil­i­ty to J&J

5 years ago
Coronavirus

Al­ca­mi ap­points new CEO in Patrick Walsh, the ex­ec­u­tive who helped lead the CD­MO's pre­de­ces­sor com­pa­ny

5 years ago
People

Pfiz­er breaks ground on ster­ile in­jecta­bles plant in Michi­gan, plans to add around 450 jobs to the re­gion

5 years ago

Covid-19 man­u­fac­tur­ing roundup: Catal­ent gets the FDA's go-ahead on J&J shot; As­traZeneca taps a new con­trac­tor

5 years ago
Coronavirus

Covid-19 roundup: Emer­gen­t's er­ror costs J&J a vac­cine batch; Pfiz­er head says EU re­stric­tions slow vac­cine dis­tri­b­u­tion process

5 years ago
Coronavirus
First page Previous page 73747576777879 Next page Last page
A service from the Financial Times